PolyPeptide

PPGN.SW

Tags: CH Healthcare Drug Manufacturers - Specialty & Generic

PolyPeptide Group Price (PPGN.SW)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

32,987,924

(0.0604)%

Market Cap of PolyPeptide (PPGN.SW)

Market cap:

As of , PPGN.SW has a market cap of . This makes PPGN.SW the 116th most valuable company in the CH by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

PolyPeptide Group AG operate as a contract development and manufacturing company worldwide. It focuses on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development, and in generic products. It engages in manufacturing custom research grade peptides; and developing neoantigen peptide to support personalized cancer therapies. The company is also involved in manufacturing peptides for commercially approved peptide therapeutics. In addition, it manufactures pepti... Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $15.26-35.8
Market Cap 599.22M
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Drug Manufacturers - Specialty & Generic

ceo: Mr. Juan Jose Gonzalez
IPO Date: April, 28, 2021
Country: CH
Currency: CHF
Headquaters: No Data
Employees: 1362

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: